226 related articles for article (PubMed ID: 12744223)
1. Eplerenone. Pharmacia.
Liew D; Martin J; Krum H
Curr Opin Investig Drugs; 2003 Mar; 4(3):316-22. PubMed ID: 12744223
[TBL] [Abstract][Full Text] [Related]
2. Eplerenone (GD Searle & Co).
Martin J; Krum H
Curr Opin Investig Drugs; 2001 Apr; 2(4):521-4. PubMed ID: 11566010
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone: cardiovascular protection.
Brown NJ
Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
[TBL] [Abstract][Full Text] [Related]
4. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
5. Eplerenone--a novel selective aldosterone blocker.
Zillich AJ; Carter BL
Ann Pharmacother; 2002 Oct; 36(10):1567-76. PubMed ID: 12243608
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone for the treatment of cardiovascular disorders.
Watanabe M; Krum H
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):831-8. PubMed ID: 22908915
[TBL] [Abstract][Full Text] [Related]
7. The role of aldosterone receptor blockade in the management of cardiovascular disease.
Liew D; Krum H
Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone antagonists in heart failure.
Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084
[TBL] [Abstract][Full Text] [Related]
9. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone.
Lainscak M; Pelliccia F; Rosano G; Vitale C; Schiariti M; Greco C; Speziale G; Gaudio C
Int J Cardiol; 2015 Dec; 200():25-9. PubMed ID: 26404748
[TBL] [Abstract][Full Text] [Related]
10. New therapy update. Inspra (eplerenone tablets).
Kloner RA
Congest Heart Fail; 2003; 9(6):341-2. PubMed ID: 14688507
[No Abstract] [Full Text] [Related]
11. [Pharmacological sheet: eplerenone (Inspra), orally].
J Pharm Belg; 2011 Sep; (3):93-4. PubMed ID: 21995102
[No Abstract] [Full Text] [Related]
12. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.
Barnes BJ; Howard PA
Ann Pharmacother; 2005 Jan; 39(1):68-76. PubMed ID: 15590870
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
Sato A
Hypertens Res; 2013 Mar; 36(3):185-90. PubMed ID: 23171954
[TBL] [Abstract][Full Text] [Related]
14. Review article: eplerenone: an underused medication?
Abuannadi M; O'Keefe JH
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):318-25. PubMed ID: 20876342
[TBL] [Abstract][Full Text] [Related]
15. Eplerenone: a selective aldosterone receptor antagonist (SARA).
Delyani JA; Rocha R; Cook CS; Tobert DS; Levin S; Roniker B; Workman DL; Sing YL; Whelihan B
Cardiovasc Drug Rev; 2001; 19(3):185-200. PubMed ID: 11607037
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.
Hu X; Li S; McMahon EG; Lala DS; Rudolph AE
Mini Rev Med Chem; 2005 Aug; 5(8):709-18. PubMed ID: 16101407
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone receptor antagonists in the treatment of heart failure.
Perkerson KA; Coleman CI; White CM
Conn Med; 2003 Aug; 67(7):397-400. PubMed ID: 14502862
[No Abstract] [Full Text] [Related]
18. Symptoms and the distress they cause: comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension.
Hollenberg NK; Williams GH; Anderson R; Akhras KS; Bittman RM; Krause SL
Arch Intern Med; 2003 Jul; 163(13):1543-8. PubMed ID: 12860576
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.
Takeda Y
Hypertens Res; 2004 Nov; 27(11):781-9. PubMed ID: 15824460
[TBL] [Abstract][Full Text] [Related]
20. [Aldosterone antagonists: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Yamamoto T
Nihon Rinsho; 2007 May; 65 Suppl 5():102-6. PubMed ID: 17571373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
